Seres Therapeutics (Formerly Seres Health, Newco LS21)

Seres Therapeutics (Formerly Seres Health, Newco LS21)

A clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Learn more

Launch date
Employees
Market cap
CAD199m
Enterprise valuation
CAD392m (Public information from Sep 2024)
Cambridge Massachusetts (HQ)
Authorizing premium user...